Cabaletta Bio, Inc.CABANASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +11.32% | +12.82% | +0.45% | +26.44% | +108.96% |
| Weighted Average Shares Diluted Growth | +12.53% | +12.97% | +0.34% | +25.14% | +106.71% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +17.96% | -27.05% | -31.32% | +3.26% | -7.17% |
| Book Value per Share Growth | -2.73% | -42.83% | -45.42% | -29.25% | -61.70% |
| Debt Growth | +256.53% | +210.88% | +252.47% | +236.39% | +69.34% |
| R&D Expense Growth | +90.69% | +46.69% | +32.18% | +60.66% | +51.48% |
| SG&A Expenses Growth | +39.90% | +44.03% | +34.29% | +13.84% | +6.82% |